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disease in South Asia (2010).
[1]
 In India, Hypertension 
is the leading cause of premature death. Hypertension 
is directly responsible for 29% of all stroke and 24% of 
heart attack in India.
[2]
 A large nationwide study 
(ICMR-INDIAB study) by Bhansali et al. reported 
Indian, 26.3% among Indian population are suffering 
from hypertension suffering from hypertension.
[3-4]
 
Hypertension is a silent killer as very rarely any 
symptom can be seen in its early stages until a severe 
medical complication takes place like heart attack, 
stroke, etc. It is most common risk factor for stroke, 
myocardial  infarction, heart failure, peripheral 
vascular disease, end stage Kidney diseases etc.  
In more than 95% of cases, specific underlying cause 
cannot be found, such patients are said to have 
Essential Hypertension.
[5]
  The pathogenesis is not 
clearly understood, many factors may contribute to its 
A B S T R A C T  
Introduction: Hypertension is an important public health challenge worldwide and remains as major cause of 
morbidity and mortality. Hypertension is the third most important attributable risk factor for burden of disease in 
South Asia (2010). In India, Hypertension is the leading cause of premature death. Hypertension is directly 
responsible for 29% of all stroke and 24% of heart attack in India. Objectives: To Evaluate the effect of 
Ashwagandhadi Churna in the management of Rakta-Gata-Vata (Essential hypertension). Materials and 
Methods: 40 clinically diagnosed patients of Essential Hypertension were selected based on inclusion criteria. 
Selected patients were randomly divided into two groups: Group A (Trial) was given Ashwagandhadi Churna in a 
dose of 3gms twice daily and Group B was given Sarpagandha Churna in a dose of 1gms twice daily with water for 
21 days. The data was graded based on assessment criteria and was analysed statistically. Results: Outcome of 
the treatment after 21 days was statistically significant in most of the sign and symptom score of various 
subjective and objective parameters. Overall it shows statistically significant result. Discussion: The total mean of 
SBP, DBP, PP and MAP before treatment was 160.10, 91.4, 65.30, 114.25 respectively after 21 days of therapy the 
total mean of SDP, DBP, MAP, and PP are 134.60, 82.60, 51.00, 98.75 respectively and all showed statistically 
significant at 0.01 except DBP which showed statistically insignificant. The mean of total cholesterol, triglycerides, 
low density lipoproteins and High density lipoproteins before treatments are 199.85, 132.05, 116.25, and 44.90 
after 21 days of therapy the total mean of total cholesterol, triglycerides, low density lipoproteins and High density 
lipoproteins are 189.60, 124.60, 109.25, 49.10 respectively and showing statistically significant at 0.01. 
Ashwagandhadi Churna is found to be effective in mild and moderate HTN and also on reducing cholesterol level 
(T.cho, TGL, and LDL) and slightly increases HDL level.  
Key words: Essential Hypertension, Rakta-gata-vata, Sarpagandha Churna, Ashwagandhadi Churna. 
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development including peripheral resistance, 
endothelial dysfunction, Autonomic tone, renal 
dysfunction, neuro-humoral factor.  
According to Ayurveda, the direct correlation for 
Hypertension is not mentioned it can be understood 
by assessing the involved Doshas, Dooshyas, Srotases 
and Sthanas etc. and it can be correlated to 
Raktagata Vata.
[6]
 In Raktagatavata, Raktadhatu get 
vitiated by Vatadosha leading to Shoshana of 
Raktadhatu and it is unable to carry out its normal 
function.
 [7]
 Symptoms like Tivraruja, Santapa, Aruchi, 
Bhrama, Klama, Krishata, Saraga, Shirashula, etc. can 
be seen in Raktagatavata.
[8-11]
  
Acharya Charaka has given a guideline to understand 
a new clinical entity not described by him in the 
Samhita. If a physician is unable to diagnose the 
disease, he should asses it’s Prakruti, Samuthan and 
Adhishtana etc. and design a treatment protocol for 
such disease.
[12] 
The study is designed to evaluate the 
efficacy of Ashwagandhadi Churna in the 
management of Raktagata Vata (Essential 
Hypertension). 
AIM AND OBJECTIVE  
1. To evaluates the efficacy of Ashwagandhadi 
Churna on essential hypertension. 
2. To find an effective safe treatment modality for 
hypertension and prevent the end organ damage. 
MATERIALS AND METHODS 
Plan of Study 
Duration of study: 21 Days 
Type of Study: Single Blind 
Type of Sampling: Randomized 
Selection of Patients 
Patients who fulfilled the inclusion criteria were 
randomly selected from OPD and IPD of Muniyal 
Institute of Ayurveda Medical Sciences and Hospital, 
Manipal and also from referral sources and special 
camps were conducted for the purpose. Both known 
cases of essential hypertension as well as newly 
diagnosed patients were included in the study as per 
classification of hypertension of 7
th
 report of Joint 
National Committee (JNC).  
Physical examination on the basis of Ayurveda and 
modern parameters was conducted for all the 
patients. Patients consent was taken and were 
examined thoroughly and the data was recorded 
systematically. A special research Performa was 
designed and duly filled for each patient.  
Diagnostic Criteria 
Objective and subjective parameters were utilized for 
diagnostic purpose. 
Objective parameter 
Systemic blood pressure is measured by 
Sphygmomanometer methods. For diagnostic purpose 
blood pressure of the patients was measured three 
times over a period of at least 3 minutes and the 
lowest reading recorded. Patients having blood 
pressure of SBP >140 mm of Hg and < 169 mm of Hg 
DBP >85 mm of Hg and <100 mm of Hg 140/90 mm of 
Hg or above were diagnosed as hypertensive and 
were selected for study. 
Subjective parameter 
 Shiroruk (Headache) 
 Bhrama (Giddiness) 
 Klama (Tireness) 
 Anidra (Insomnia) 
 Kroda Prachurata (Anger) 
 Tivrashula (Severe ischemic pain) 
Inclusion criteria  
 Age between 30 to 70 years.  
 Either sex, irrespective of religion, caste. 
 Blood pressure - Systolic blood pressure 140-169 
mmHg and Diastolic blood pressure 90-99mmHg.  
Exclusion criteria 
 Patients having hypertension due to other 
secondary disease like renal disease, endocrinal   
Disorder, Neurogenic causes, etc. 
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 Cerebrovascular disease (Coronary Heart 
Diseases, Left Ventricular   Hypertrophy and 
Failure)  
 Malignant Hypertension, Patients having 
complication of hypertension.  
Criteria for Withdrawal 
 If there is aggravation of complaint 
 Personal matters 
 Medical advice 
Selection of Drug 
Ashwagandhadi Churna is selected for the present 
study. Ashwagandhadi Churna contains 
Ashwagandha, Trikatu (Shunthi, Pipalli, Maricha), Ela, 
Vidanga and Nagkeshara. Research has been done on 
the effective of Ashwagandha root Powder in 
treatment of mild and moderate HTN. In national 
health portal they have mentioned the used of single 
Ashwagandha root powder for treatment of high 
blood pressure.
[14]
 Ashwagandhadi Churna is 
mentioned in Sahasrayoga in Churna for the 
treatment of Vata Roga.
[15]
  
Constituents of Ashwagandhadi Churna 
Ashwagandha (Whithania 
somnifera) 
Root 64 part 
Shunthi  (Zingiber officinale) Rhizome 32 part 
Pippali (Piper longum) Fruit 16 part 
Maricha (Piper nigrum) Fruit 8 part 
Ela (Elletaria cardamum) Seed 4 part 




Sharkara  127 part 
The drug was prepared by processing the grinding of 
raw drugs into Churna. 
Grouping of patients 
A minimum of 40 patients who fulfilled the diagnostic 
and inclusion criteria irrespective of their gender, 
caste, religion, education status and socio-economic 
status were taken for the study. Registered patients 
were allotted randomly by lottery method into two 
equal groups of minimum 20 patients in each as 
Group A and B. In Group A: were given with 
Ashwagandhadi Churna 3 gm twice daily after food. In 
Group B: were given with Sarpagandha Churna 1gm 
twice daily after food. Treatment duration: 21days, 
Anupana: Water. 
The Regimen to be followed along with medicine 
Ahara: Diets rich in fruits, vegetables, fat-free or low-
fat milk and milk products, whole grains, fish, poultry, 
beans, seeds and nuts. It also contains less sodium; 
sweets, added sugars and beverages containing sugar; 
fats. Also lower in saturated fat, Trans fat and 
cholesterol and rich in nutrients that are associated 
with lowering blood pressure mainly potassium, 
magnesium, calcium, protein and fibres.  
Investigations 
 Lipid profile: S. Cholesterol, TG, LDL, HDL, and 
VLDL were done before and after the treatment. 
 Other investigation was carried out, to rule out 
secondary hypertension or any other pathologic 
condition 
Follow up Study 
After completion of therapy patients were advice to 
report once a week for 15 days. 
Assessment criteria for Overall Effect of Therapy 
The data were analyzed in the following sequence; 
 General observation 
 Results of treatment on basis of signs and 
symptoms, Blood pressure reading and 
Biochemical parameters. 
Statistical Analysis 
The obtained information was analyzed statistically in 
terms of Mean Score (x), Standard Deviation (S.D.) 
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and Standard Error (S.E.). Paired ‘t’ test and Unpaired 
‘t’ test was carried out at the level of 0.05, 0.01 and 
0.001 of P levels.  
The results were interpreted as: 
 P<0.05 - Improvement 
 P<0.01 - Significant improvement 
 P<0.001 - Highly significant improvement 
Criteria of Assessment of Result 
 Controlled Relief: 100% relief in complaints 
 Marked Relief: >75% relief in complaints 
 Moderate Relief: 50 -74% relief in complaints 
 Mild Relief: 25 - 49 % relief in complaints 
 No Relief: 0- 25 % relief in complaints 
RESULT 
In present research work, Maximum number of 
patients were belonging to Madhyama Vayas i.e. 41-
60 years (80.5%), Majority of the patients were males 
(55%) and Vata-Pittaja Prakriti (Physical constitution) 
(72.5 %) and 82.5% were of middle class. Lifestyle of 
47.5 % patients was sedentary and 12.5% patients had 
addiction of smoking and alcohol. Symptoms recorded 
in the patients were Shiroruka (67.5%), Anidra 
(62.5%), Bhrama (70%), Klama (75%), 
Krodhaprachurata (60%).  
Effect of therapy on group-A (Ashwagandhadi 
Churna) 
Effect on blood pressure: Systolic Blood Pressure: The 
mean score of SBP prior to treatment was 160.10, 
which was reduced to 134.60, giving 16.50 % relief. 
This result was statistically significant at p=0.001. 
Diastolic Blood Pressure: The mean score of DBP prior 
to treatment was 91.40, which was reduced to 82.60, 
giving 9.902% relief. This result was statistically 
insignificant as p=0.132. Effect on Pulse Pressure: The 
mean score of PP prior to treatment was 65.30, which 
was reduced to 51.00, giving 22.49 % relief. This result 
was statistically significant at p<0.05. Mean Arterial 
Pressure: The mean score of M.A.P prior to treatment 
was 114.25, which was reduced to 98.75, giving 14.09 
% relief. This result was statistically significant at 
p<0.05.  
Effect on sign and symptom: Shiroruk (Headache): 
The mean score of Shiroruka prior to treatment was 
1.90, which was reduced to 0.70, giving 63.157% 
relief. This result was statistically significant at 
p<0.001. Bhrama (Giddiness): The mean score of 
Bhrama prior to treatment was 1.35, which was 
reduced to 0.50, giving 62.96% relief. This result was 
statistically highly significant at p<0. 001. Klama 
(fatigue): The mean score of Klama prior to treatment 
was 1.65, which was reduced to 0.40, giving 84.84% 
relief. This result was statistically highly significant at 
p<0.001. Anidra (Insomnia): The mean score of Anidra 
prior to treatment was 1.50, which was reduced to 
0.60, giving 63.33% relief. This result was statistically 
significant at p<0.001. Krodhaswabhava: The mean 
score of Krodhaswabhava (irritability) prior to 
treatment was 1.10, which was reduced to 0.40, 
giving 63.63% relief. This result was statistically 
significant at p<0.001.  
Effect on cholesterol: Total Cholesterol: The mean 
score of T. Cholesterol prior to treatment was 199.85 
which were reduced to 189.60, giving 8.81% relief. 
This result was statistically significant as p<0.001. 
Triglycerides: The mean score of Triglycerides prior to 
treatment was 133.05, which was reduced to 124.90, 
giving 6.125% relief. This result was statistically 
significant at p<0.001. HDL: The mean score of HDL 
prior to treatment was 44.90, which was increase to 
51.10, giving 12.13% relief. This result was statistically 
significant at p<0.001. LDL: The mean score of LDL 
prior to treatment was 116.25, which was reduced to 
109.25, giving 6.021% relief. This result was 
statistically significant at p<0.001.  
Effect of therapy on group B (Sarpagandha Churna) 
Effect on blood pressure: Systolic Blood Pressure: The 
mean score of SBP was 158.80 and it reduced to 
128.80 after treatment. The relief was 18.39% with 
giving significant result at p<0.001. Diastolic Blood 
Pressure: The mean score of DBP was 90.70 and it 
reduced to 79.60 after treatment. The relief was 
12.24% with giving significant result at p<0.001. Pulse 
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Pressure: The mean score of PP was 68.10 and it 
reduced to 48.10 after treatment. The relief was 29.36 
% with giving significant result at p<0.001. Mean 
Arterial Pressure: The mean score of M.A.P was 
113.40 and it reduced to 96.15 after treatment. The 
relief was 15.40% with giving significant result at 
p<0.001.  
Effect on sign and symptom: Shiroruk (Headache): 
The mean score of Shiroruka was 1.45 and it reduced 
to 0.55 after treatment. The relief was 62.06% with 
giving significant result at p<0.001. Bhrama 
(Giddiness): The mean score of Bhrama was 1.45 and 
it reduced to 0.30 after treatment. The relief was 
79.31% with giving significant result at p<0.05. Klama 
(fatigue): The mean score of Klama was 1.60 and it 
reduced to 0.80 after treatment. The relief was 50% 
with giving significant result at p<0.05.  Anidra 
(Insomnia): The mean score of Anidra was 1.60 and it 
reduced to 0.80 after treatment. The relief was 75% 
with giving significant result at p<0.05. 
Krodhaswabhava: The mean score of 
Krodhaswabhava was 1.00 and it reduced to 0.35 
after treatment. The relief was 65% with giving 
significant result at p=0.001. 
Effect on cholesterol: Total Cholesterol: The mean 
score of T. Cholesterol was 174.35, and it reduced to 
170.50 after treatment. The relief was 5.22% with 
giving not significant result as p=0.751. Triglycerides: 
The mean score of Triglycerides was 141.40 and it 
reduced to 134.40 after treatment. The relief was 
4.95% with giving significant result at p<0.001. HDL: 
The mean score of HDL was 44.90 and it increase to 
51.10 after treatment. The relief was 13.80 % with 
giving significant result at p<0.001. LDL: The mean 
score of LDL was 118.55 and it reduced to 111.85 
after treatment. The relief was 5.65 % with giving 
significant result at p<0.001. 
Overall effect of therapy: Group A ( trial Group) out 
of the 20 individuals in sign and symptom, 6 showed 
controlled relief, 12 showed marked reliefs and 2 
moderate reliefs. In lowering Systolic blood pressure, 
10 showed marked relief, 6 show moderate relief and 
4 showed mild relief. In reducing Diastolic blood 
pressure, 2 show moderately relief, 14 mild relief and 
4 no relief. Percentage of relief of in T. Cholesterol, 
TGL, HDL and LDL are 9.48%, 6.125%, 8.36%, 6.021% 
respectively. Group - B: Out of 20 patients 7 showed 
control relief, 13 marked reliefs in sign and symptom; 
In lowering SBP, 3 showed controlled relief, 7 showed 
marked relief, 6 showed moderately relief and 4 
showed mild relief: In reducing DBP 2 showed 
controlled relief, 14 showed marked relief, 2 showed 
moderately relief and 2 showed mild relief: 
Percentage of relief of in T. Cholesterol, TGL, HDL, and  
LDL are 5.22%, 4.95%, 6.90%, 5.65% respectively 
Adverse effects: No adverse effects were observed in 
any patient throughout the study. 
DISCUSSION 
Essential Hypertension is a psychosomatic 
hemodynamic disease with a multi-factorial pathology 
and origin of several dietary, environmental and 
genetic factors. Numerous researches have been 
done, yet, there is a necessity for pursuing further 
research to find out some safe and effective therapy 
with no adverse effects and to prevent from life 
threatening complications of the Hypertension and 
save the Hypertensive population.  
EHT is a Vata-Pitta Pradhana Tridoshaja Vyadhi and 
the main pathogenesis occurs in Rasa, Rakta Dhatu 
and Upadhatu (Sira and Dhamani). Vyana Vayu which 
is the main Vayu responsible for the maintenance or 
pumping function of the blood. It vitiation will lead 
over contraction of heart and increases of pressure in 
the blood vessel. If left untreated or its normal Gati 
it’s not bring back to normal it will further causes 
Sankoch of Vahinies and by its Ruksha Guna it will 
dries up the inner Uplepa of Malarupa Kapha; 
enhances the process of Kathinya. Due to this there is 
narrow of pathway of circulation and Avarodha occurs 
in Rasa-Rakta Vikshepana Karma, causing forceful 
function of Vyana Vayu with increase of its Chala 
Guna. Due to which Vyana Vayu has to exert more 
pressure on the wall of Dhamani (blood vessels) to 
provide nourishment to different body part and lead 
to Essential Hypertension. 
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After 21 days of treatment of Ashwagandhadi Churna 
SBP was reduced by 18.6% from 153.7mmHg to 
124.9mmHg.  DBP was reduced by 18.5% from 103.7 
to 84.4mmHg. The therapy significantly reduced mean 
pulse pressure by 18.8% from 49.8mmHg to 
40.4mmHg and mean arterial pressure by 19.05% 
from 120.3mmHg to 97.4mmHg. The therapy 
produced highly significant result in Shiroruka, Klama, 
Anidra, Bhrama and decrease in Irritability.  Hence it 
can be concluded that Ashwagandhadi Churna 
brought significant changes in blood pressure with 
decrease of symptoms associated with essential 
hypertension and reduce in blood pressure to normal 
limits.  
Probable mode of action of the drug 
Probable mode of action of drugs may be because 
they have different pharmacodynamic properties due 
to which, multiple mechanism of actions taken place 
at different sites which may be responsible for 
disruption of pathogenesis of disease. 
Ashwagandhadi Churna with Ashwagandha as its 
main ingredients mainly acts on vitiated Vata Kapha 
Dosha but also has Pittahara properties because of 
Madhura Vipaka, Tikta Guna Phadhana and Sharkara 
contain in it, thereby helps to alleviate the Samprapti 
of disease. The drug act as Deepana, Pachana 
(Ashwagandha, Trikatu) properties helps to alleviate 
obstruction in the Strotasa due to Ama resulting into 
Stroto Shodhana and Vatanulomana. Ashwagandha is 
also having Mutrala properties thereby removing 
Kleda in the body and also reduces cardiac volume. 
The Whithanoloides extracts of Ashwagandha show 
significant effect in reducing serum cholesterol levels 
by its antioxidants properties, it does scavenging the 
free radicals, so that excess LDL are not oxidized 
inside the artery to form plague, thereby preventing 
atherosclerosis and other  risk of coronary artery 
diseases, heart failure etc. On the other hand, 
significantly increased plasma HDL-cholesterol 
levels.
[16]
 Ashwagandha is considered a nervine tonic 
with adaptogenic action, anti-stress properties, 
balances the stress hormones and reduces the cortisol 
levels and mitigates the stress induced hypertension. 
According to Mehra et al. (2009) reported that 
Ashwagandha is advocated as a protrective drugs 
against atherosclerosis, hypertension and coronry 
heart diseases. Ashwagandha alone is used for the 
treatment of mild and moderate Hypertension. The 
roots and leaves of Ashwagandha are used 
traditionally in the form of powder; decoction, oil etc 
are used in folk medicine against general disability, 
hypertension, inflammations and wounds.
[17] 
Trikatu (Shunthi, Pippali, Marichi) has got a 
tremendous potential to increase the bioavailability of 
drugs and nutrients. It will help in action of main 
drugs by increasing the bioavailability of the drug 
across the membrane. Zingiber officinale has 
properties which improved blood circulation and 
relaxes muscles surrounding blood vessels lead to fall 
in the arterial BP. It has Ca
2+
 channel-blocking activity 
indicate that the BP lowering effect of ginger similar 




Hypertension is Vata Pradhan Tridosha Vyadhi, Rasa 
Rakta as main Dushyas, Rasavaha, Raktavaha and 
Manovaha Srotasa as the main symptom involved. In 
Raktagata Vata the vitiated Vata get lodged in the 
Rakta  Dhatu leading to Soshana of Rakta Dhatu. 
Ashwagandha have actions of scavenging free 
radicals, inhibit lipid peroxidation, delayed the plasma 
re-calcification time and enhances the release of 
lipoprotein lipase enzyme. It reduces the total 
cholesterol and triglycerides and increases high 
density lipoprotein cholesterol. In the present trial, 
Ashwagandhadi Churna show effective in the 
management of mild and moderate blood pressure 
and also effective in reducing blood Cholesterol Level. 
Ashwagandha alone is used for the treatment of mild 
and moderate Hypertension.  
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